Towards defining the functional methylome in acute lymphoblastic leukemia
Towards defining the functional methylome in acute lymphoblastic leukemia
批准号:
8329703
负责人:
KRISTEN H TAYLOR
金额:
$23.56万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2014-07-31
关键词:
Acute Lymphocytic LeukemiaAgeB-LymphocytesBiological SciencesBone MarrowCancer EtiologyCandidate Disease GeneChildhood Acute Lymphocytic LeukemiaCollaborationsCommitCommunitiesCpG IslandsCytosineDNA MethylationDataDiagnosticDiseaseDown-RegulationEpigenetic ProcessEquipmentEventFacultyFoundationsGene ExpressionGene SilencingGenerationsGenesGeneticGenomeGenomicsGoalsHot SpotHumanIndividualInstitutionInstructionInvestigationKnowledgeLeadLocationMalignant - descriptorMalignant NeoplasmsMapsMentorsMethylationMissouriNucleic Acid Regulatory SequencesPatientsPatternPerinatal ExposurePhenotypePrognostic MarkerResearchResearch PersonnelResolutionSiteSpecimenTechnologyTestingTimeTrainingTumor Suppressor GenesUniversitiesWorkbasebisulfitecareercareer developmentdensitygene functiongenome-wideinhibitor/antagonistmedical schoolsmemberneoplasticnovelpromoterresponsible research conductsextechnical writingtumor
中文摘要
到目前为止,对候选基因的DNA甲基化或使用低分辨率全基因组技术的研究已经
提供了存在于各种肿瘤类型中的异常甲基化的不完整视图。当前的目标是
建议缩小这一知识差距,并阐明造成这种异常的机制(S)
急性淋巴细胞白血病(ALL)基因甲基化的疾病特异性靶向性研究我们建议追求三个目标
目的:L)在正常和恶性前体B细胞中生成高分辨率的全基因组甲基化图谱
对照和儿童个体都使用全基因组甲基化微阵列;2)阐明序列特异性
通过比较肿瘤中CGI甲基化模式和区域特异性异常甲基化靶点
和正常骨髓;以及3)生成CpG位点特定的CGI甲基化图谱以确定这些关系
使用大规模并行测序技术在甲基化位置和程度与基因表达之间的关系
QRT-PCR法。这项工作将推动对ALL甲基组的破译及其对ALL表型的贡献
开发的分析策略应该为研究其他基因异常甲基化定义一个很好的模板
肿瘤类型。拟议的调查将为候选人的长期职业目标提供基础
成为一级研究机构的独立研究员和教员,长期目标:1)
研究遗传学和表观遗传学之间的关系;以及2)调查宫内妊娠的后果
将继续就表观遗传事件的建立进行曝光。培训计划包括高级分析、癌症病理生物学、科学写作和技术培训。还包括职业发展活动,如建立网络、提供科学数据的机会、一对一指导和负责任的研究工作培训。培训将由密苏里大学医学院的M.Sharon Stack博士和Charles Caldwell博士指导。Stack博士将通过帮助候选人融入地方和国家两级的科学界,帮助候选人过渡到独立。考德威尔博士将通过向候选人公布所有数据,促进新的合作,并承诺完成培训所需的资金、设施、设备和技术支持,帮助候选人过渡到独立。
英文摘要
To date, investigations of DNA methylation in candidate genes or using low-resolution genome-wide technologies have
provided an incomplete view of the aberrant methylation present in various tumor types. The immediate goal of the
proposal is to narrow this knowledge gap and to elucidate the mechanism(s) that are responsible for the aberrant
disease-specific targeting of loci methylated in acute lymphoblastic leukemia (ALL). We propose to pursue three
aims:l) Generate high-resolution, genome-wide methylation profiles in normal and malignant precursor B-cells from
controls and individuals with childhood ALL using a genome-wide methylation microarray; 2) Elucidate sequencespecific
and region-specific targets of aberrant methylation by comparing CGI methylation patterns among neoplastic
and normal bone marrows; and 3) Generate CpG site-specific CGI methylation maps to determine the relationships
between location and extent of methylation and gene expression using a massively parallel sequencing technology and
qRT-PCR. This work will progress the deciphering of the ALL methylome and its contribution to the ALL phenotype
and the developed analytical strategy should define an excellent template for studying aberrant methylation in other
tumor types. The proposed investigations will provide the foundation for the candidate's long-term career goal to
become an independent researcher and faculty member at a Tier I research institution where, the long-term objectives: 1)
Researching the relationships between genetics and epigenetics; and 2) Investigating the consequences of in utero
exposures on the establishment of epigenetic events will be pursued. The training plan includes advanced analytical, cancer pathobiology, scientific writing and technical training. Also included are career development activities such as networking, opportunities to present scientific data, one-on-one mentoring and training in the responsible conduct of research. The training will be under the tutelage of Dr. M. Sharon Stack and Dr. Charles Caldwell at the University of Missouri-School of Medicine. Dr. Stack will assist the candidate in the transition to independence by aiding in the candidate's integration into the scientific community both at the local and national levels. Dr. Caldwell will assist the candidate in the transition to independence by releasing all data to the candidate, facilitating new collaborations, and committing the finances, facilities, equipment and technical support required to complete the training.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Towards defining the functional methylome in acute lymphoblastic leukemia
-
批准号:8537120
-
项目类别:
-
资助金额:$21.64万
-
财政年份:2009
-
负责人:KRISTEN H TAYLOR
-
依托单位:
Towards defining the functional methylome in acute lymphoblastic leukemia
-
批准号:8305186
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2009
-
负责人:KRISTEN H TAYLOR
-
依托单位:
Toward Defining the Functional Methylome in Acute Lymphoblastic Leukemia
-
批准号:7587583
-
项目类别:
-
资助金额:$11.32万
-
财政年份:2009
-
负责人:KRISTEN H TAYLOR
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: